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Abstract: Exercise-induced pulmonary haemorrhage (EIPH) occurs in horses performing high-
intensity athletic activity. The application of physics principles to derive a ‘physical model’, which 
is coherent with existing physiology and cell biology data, shows that critical parameters for 
capillary rupture are cell–cell adhesion and cell stiffness (cytoskeleton organisation). Specifically, 
length of fracture in the capillary is a ratio between the energy involved in cell–cell adhesion and 
the stiffness of cells suggesting that if the adhesion diminishes and/or that the stiffness of cells 
increases EIPH is more likely to occur. To identify genes associated with relevant cellular or 
physiological phenotypes, the physical model was used in a post-genome-wide association study 
(GWAS) to define gene sets associated with the model parameters. The primary study was a GWAS 
of EIPH where the phenotype was based on weekly tracheal wash samples collected over a two-
year period from 72 horses in a flat race training yard. The EIPH phenotype was determined from 
cytological analysis of the tracheal wash samples, by scoring for the presence of red blood cells and 
haemosiderophages. Genotyping was performed using the Illumina Equine SNP50 BeadChip and 
analysed using linear regression in PLINK. Genes within significant genome regions were selected 
for sets based on their GeneOntology biological process, and analysed using fastBAT. The gene set 
analysis showed that genes associated with cell stiffness (cytoskeleton organisation) and blood flow 
have the most significant impact on EIPH risk. 
Keywords: exercise-induced pulmonary haemorrhage; horse; genome-wide association; capillary 
fracture; cell–cell adhesion; cell cytoskeleton stiffness; blood flow 
 
1. Introduction 
Exercise-induced pulmonary haemorrhage (EIPH) is frequently identified in horses performing 
high-intensity athletic activity. During exercise the pressure in the pulmonary capillaries reaches at 
least 80 mmHg [1], which is sufficient to cause pulmonary capillary stress failure [2,3]. Additionally, 
high transmural pressure (difference between the positive intraluminal and negative alveolar 
pressures) causes rupture of the blood-gas barrier [4]. The cause of bleeding is capillary failure; 
bleeding stops when the pressure is reduced [5] but lung lesions remain in horses with EIPH 
suggesting the condition is due to more than simple stress failure [6–8]. During exercise, raised left 
atrial pressure causes blood to back up into the lungs leading to an increase in pulmonary capillary 
pressure [9]. As a result, in EIPH lung lesions the small pulmonary veins (100–200 µm outer diameter) 
are remodelled through the build-up of adventitial collagen and hyperplasia of smooth muscle [5] 
which can lead to a significant reduction in the vascular lumen [6–8]. 
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EIPH lung lesions have been observed in unraced Thoroughbreds in training [10], suggesting 
that venous remodelling may begin when horses first enter training. It has been hypothesised that 
the frequency and duration of ‘high-pressure events (HPE)’—gallops during training or races—and 
the horse’s genetic susceptibility to vascular weakness will determine the degree of venous 
remodelling seen in an individual horse [5]. This hypothesis is supported by observations that 
pulmonary veins are stiffer in raced than unraced horses [11], and that number of lifetime starts rather 
than age correlates with EIPH [12]. Long term prognosis for horses with EIPH is poor, there is no 
cure and the only way to allow horses to recover is by giving them enough rest time between races 
or by retiring them [13]. 
Historically there have been many documented references to racehorses who were ‘bleeders’. 
The earliest recorded was a horse called ‘Bartlett’s Childers’ (born 1716), who was the great-grandsire 
of the stallion ‘Eclipse’, others have included ‘Herod’ (born 1758) and ‘Hermit’ (born 1864). Amongst 
modern-day Thoroughbred sires, more than 95% can trace their ancestry to ‘Eclipse’ [14]. The 
heritability of epistaxis (when blood is visible at the nostrils) in UK, Australian, South African and 
Hong Kong Thoroughbreds has been evaluated based on pedigree analysis, and estimated at 0.3–0.5 
[15–17] providing clear evidence of a genetic basis to EIPH risk, although the aetiology is complex. 
Genome-wide association studies (GWAS) have played a key role in the search for genetic 
variants associated with complex traits and several secondary analysis methods have been proposed 
for fine mapping of causal variants within an associated genome region, or for prioritizing variants 
based on functional annotation. Complex traits involve multiple genes and the impossibility of 
considering single variants without the context of their genetic background has led to the 
development of several methods that explore the combined effects of many genes. Gene set analyses 
are a popular approach, as they can give insight into disease mechanisms and functional context for 
individual single nucleotide polymorphism (SNP) associations [18]. In this study we show how a 
physics-inspired model of EIPH can be used to define gene sets based on parameters having a 
significant influence on the model, namely cell–cell adhesion, cell stiffness (cytoskeleton 
organisation) and blood flow. This enables gene sets to be refined according to biological functions 
which specifically affect the physical phenotype. 
2. Materials and Methods 
2.1. Tracheal Wash Sampling 
Tracheal wash samples were collected from 106 thoroughbred horses in a flat racing training 
yard by the same veterinary surgeon. Samples were collected on a weekly basis from March 2009 to 
November 2010, with 41 horses sampled in 2009, 42 horses sampled in 2010 and 23 horses sampled 
in both 2009 and 2010. During the sampling period, all horses were in training and raced at regular 
intervals. The tracheal wash (TW) samples were obtained transendoscopically post-exercise during 
training, using the biopsy probe of a flexible endoscope. Sample collection and handling protocols 
were reviewed and approved by the Ethics Committee at the Animal Health Trust (AHT01-2008). 
Only horses that were sampled on four or more occasions during the sampling period and whose 
genotyping data passed genotyping quality control were included in this study. This left a total of 72 
horses in the study, 32 males and 40 females. 
2.2. Tracheal Wash Cytology 
Tracheal wash samples were formalin-fixed at the point of collection. The wash sample was 
centrifuged, and a portion of the cell pellet was pipetted onto a Poly-L-Lysine glass slide and 
smeared. In samples where a reasonably sized pellet was not visible after centrifugation, slides were 
prepared using cytospin centrifugation. All slides were air-dried, stained using Haematoxylin and 
Eosin stains and examined using light microscopy. Each sample was evaluated for the presence of 
epithelial cells, macrophages, lymphocytes, eosinophils, haemosiderophages (HF), erythrocytes or 
red blood cells (RBC), squames, mucus, fungi, bacteria, plant material and debris. Each of these cell 
types or characteristics was assigned a score out of three indicating a relative density, with a score of 
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0 equating to none, score of 1 to occasional, score of 2 to moderate and a score of 3 to high (see 
Appendix A for cytology images). Overall cell density was scored out of 3; a score of 0 equated to 
low/medium-low, a score of 1 to medium, a score of 2 to medium-high and a score of 3 to high. 
2.3. EIPH Phenotype 
EIPH is defined as blood in the airways after exercise and may be detected by 
tracheobronchoscopic examination and/or by enumerating red blood cells or haemosiderophages in 
cytology samples from tracheal wash (TW) or bronchoalveolar lavage (BAL) fluid [19]. BAL requires 
sedation and local anaesthesia of the horse, as the endoscope is passed further than the trachea and 
into a subsegmental bronchus [20]. The need for sedation and local anaesthesia means that the routine 
use of BAL on horses engaged in both training exercise and racing is not acceptable to trainers, hence 
this study was based on routine (weekly) tracheoendoscopic examination and TW sampling rather 
than BAL. The occurrence of EIPH was determined by cytological analysis of the TW samples to score 
the presence of red blood cells and haemosiderophages (macrophages which have phagocytized red 
blood cells in the alveolar space or airways). Red blood cells are detectable immediately post-exercise 
in BAL fluid, while the percentage of haemosiderophages significantly increases one week after 
exercise returning to pre-exercise levels within three weeks [21]. Although TW does not directly 
correlate with BAL cytology [20], the numbers of haemosiderophages may be used to detect EIPH in 
TW samples [22]. While the precise timing of haemorrhage is difficult to determine from TW samples, 
an increased frequency of haemosiderophage score during the time period of sampling indicates 
persistent episodes of bleeding after training and racing. In this study, the EIPH phenotype was 
obtained as a frequency score for each horse calculated as the sum of the HF scores (>1) over the series 
of tracheal wash samples taken on that individual divided by the total number of samples in the 
series. 
2.4. Horse Race Record 
The number of races starts in both 2009 and 2010, dates of first and last race start for both 2009 
and 2010, gender and date of birth for each horse was obtained by searching the Racing Post Online 
database (http://www.racingpost.co.uk). This information was used to calculate the age of each horse 
at first race start for both 2009 and 2010, and the age of each horse when the first tracheal wash sample 
was collected. The age of the horse at first race start and age at first tracheal wash sampling was 
significantly correlated (r = 0.895). The number of days between the last race start and each tracheal 
wash sampling was also calculated. 
2.5. DNA Extraction and Quantification 
Blood samples from each horse were collected for routine haematology testing as part of the 
animal’s training regime by a veterinary surgeon, and residual samples were used for DNA 
extraction. DNA was extracted using nucleon BACC DNA extraction kits. Samples were quantified 
in duplicate using Quant_iT PicoGreen dsDNA kits (Invitrogen Carlsbad, CA, USA) and 10% of the 
samples were run on a 1% agarose gel to check for the presence of high molecular weight DNA. DNA 
aliquots were adjusted to a concentration of 70 ng/uL for genotyping. 
2.6. Single Nucleotide Polymorphism (SNP) Genotyping and Quality Control 
Samples were genotyped using the Equine SNP50 BeadChip (Illumina, San Diego, CA, USA). 
This array consists of 54,602 SNP (single nucleotide polymorphisms) assays, all of which are derived 
from the EquCab2.0 SNP collection (http://www.broadinstitute.org/mammals/horse). SNPs are 
evenly distributed throughout the equine genome, with an average density of one SNP per 43.2 kb. 
The genotyping data were analysed with GenomeStudio software (Illumina, San Diego, CA, 
USA) using a cluster file generated from a dataset of 1342 Thoroughbred samples previously 
genotyped with the Equine SNP50 BeadChip. SNPs with low intensity data (190 SNPs), with 
inadequately defined clusters (1265 SNPs), with call rates less than 98% (2279 SNPs), where the 
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heterozygote cluster was insufficiently separated from the homozygote clusters (297 SNPs), where 
genotypes differed significantly from Hardy–Weinberg equilibrium (119 SNPs) and where X 
chromosomes SNPs were heterozygous in males (52 SNPs) were removed. Additionally, SNPs for 
which more than 10% of genotypes were missing, markers that failed the Hardy–Weinberg 
equilibrium test (p < 0.001), and markers with a minor allele frequency (MAF) less than 2% were 
removed leaving a total of 43,465 SNPs in the analysis. 
2.7. Population Structure 
Possible population stratification was assessed by calculating identity-by-state (IBS) sharing 
among all pairs of individuals. A permutation test for between-group IBS differences was carried out 
in PLINK v1.07 [23]. Groups were defined as horses with HF frequency score greater than zero (EIPH 
affected) or equal to zero (unaffected). The IBS relationships among individuals were visualised using 
multidimensional scaling to plot the genetic relationship matrix (Figure 1). 
 
Figure 1. Multidimensional scaling (MDS) plot of genetic relationship among all individuals, 
calculated from the whole genome single nucleotide polymorphism (SNP) genotypes. The outlying 
clusters represent three half-sibling families. 
2.8. Linear Regression Association Analysis 
An association analysis to identify SNPs significantly associated with EIPH was carried out 
using the linear regression option in PLINK v1.07 [23]. Each SNP is analysed independently (single 
SNP analysis), with a regression coefficient significantly different from zero indicating a relationship 
between the genotype at that SNP and the phenotype. A t-test is used to test whether or not the 
coefficient is significantly different from zero. Linear regression analysis also allows for the testing of 
disease trait SNP associations along with interaction with defined co-variates. Covariates 
incorporated into the association analysis included gender, age of horse at first race start within the 
period of time when tracheal wash sampling occurred, period(s) of time when tracheal wash 
sampling occurred and the average number of days to last race start before tracheal wash sampling 
occurred. A Bonferroni correction was applied to adjust the significance of p-values to account for 
multiple testing; in this case, 43,417 SNPs were tested. A p-value was considered to be significant 
when p < 1.15 × 10−6. 
2.9. Estimation of the Genetic Variance Explained by Individual Chromosome SNPs 
Restricted maximum likelihood (REML) analysis with the GCTA program [24] was used to 
obtain estimates of the genetic variance explained by SNPs on individual chromosomes. 
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2.10. Gene Set Analysis 
The physical model of EIPH described in Appendix B shows that sustained bleeding will occur 
when capillary fracture reaches a critical length, the length being determined by the ratio between 
the energy involved in cell–cell adhesion and the stiffness (cytoskeleton organisation) of cells. Genetic 
variants that decrease cell–cell adhesion or increase cell stiffness are, therefore, likely to enhance 
susceptibility to EIPH. The model also suggests that factors modulating blood flow, such as a 
reduction in blood vessel diameter or an increase in cardiac output, would increase susceptibility to 
EIPH. The key parameters modulating risk are, therefore, cell–cell adhesion, cell stiffness and blood 
flow. To identify whether genetic variants identified through the GWAS significantly affected these 
parameters a gene set analysis was carried out, assigning SNPs from genome regions significantly 
associated with EIPH to gene sets based on their proximity to known or predicted genes with 
functions linked to these parameters. 
Genes in the genome regions demarcated by the top 20 GWAS SNPs ranked on p-value were 
identified in the Ensembl genome browser (www.ensembl.org), and gene annotations were identified 
by comparison with the syntenic human regions. Gene function analysis and assignment to Gene 
Ontology (GO) classifications were carried out using DAVID [25] and Amigo2 [26]. Based on the prior 
information provided by the physics model, and using GO classifications as gene function, genes 
were grouped into sets with functions relating to (i) cell–cell adhesion (ii) cytoskeleton organisation 
(cell stiffness) and (iii) blood flow. For comparison gene sets representing (iv) disease biomarkers 
(stroke or hypertension) and (v) random background markers (genes within the significant GWAS 
genome regions but having functions unrelated to the parameters of interest) were also constructed. 
The GO terms used to classify the gene sets are shown in the Supplementary File: Table S1 Gene 
Ontology Terms. 
For each gene, the chromosome position, gene start and end positions were identified using 
Ensembl BioMart [27]. SNPs on the Equine SNP50 BeadChip were then assigned to genes within the 
gene sets if they were located within the gene boundaries (end-start), or within 5 kb or within 20 kb 
of the gene start or end. 
Gene set analysis was carried out using fast set-based association analysis (fastBAT) [28]. SNPs 
in genes that appeared in the intersect between sets (i) cell–cell adhesion, (ii) cytoskeleton 
organisation (cell stiffness) and (iii) blood flow were further analysed for haplotype associations and 
SNP–SNP epistatic interactions using PLINK v1.07 [23]. 
3. Results 
3.1. Population Structure 
All sampled individuals came from bloodlines which predominantly represent the UK 
Thoroughbred population. Figure 1 shows the majority of individuals were in a central cluster, with 
three outlying clusters representing three separate sire families. All three of these families trace back 
to a single sire within three or four generations. The structure seen in the data, therefore, represents 
close family structure within the breed. There was no significant difference in IBS between groups 
(horse with HF scores > 1 were defined as cases, all others as controls), with the proportion of variance 
in IBS between groups = 0.0002, confirming there is no significant stratification within this population. 
3.2. Genome-Wide Association Analysis (GWAS) 
Genome-wide significant single nucleotide polymorphisms (SNPs), after adjusting the p-values 
for multiple testing (p < 1.15 × 10−6), were found on chromosomes 3, 13 and 23 for haemosiderophage 
frequency (number of times HF score > 1). Suggestive signals for haemosiderophage frequency (HF), 
not quite reaching genome-wide significance, were found for genome regions on chromosomes 1, 14 
and 25. Figure 2 illustrates the genome-wide association results for all SNPs. Appendix C shows the 
top 20 SNPs from the GWAS, ranked by smallest to largest p-value. 
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(a) (b) 
Figure 2. Genome-wide association study results: (a) Manhattan plot showing the –log10 (p-values) for 
relative sum of haemosiderophage frequency (HF) score > 1 plotted against SNPs colour coded by 
chromosome; (b) Quantile–quantile (QQ) plot of expected versus observed p-values with a genomic 
inflation factor (λ) = 0.993. 
SNP genetic variances estimated for each chromosome are listed in the Supplementary file: Table 
S2 SNP based Estimates of Genetic Variance. Genetic variances significantly different from zero were 
identified on chromosomes 13, 19 and 20. 
3.3. Gene Set Analysis 
Table 1 shows the GWAS genome regions from which gene lists were identified. The 
GAD_Disease, Gene Ontology terms, KEGG Pathway and UP Keywords associated with all genes 
identified in the significant genome regions are listed in the Supplementary file: Table S3 EIPH Top 
20 SNPs Gene Functions. Gene sets were constructed based on these terms, in total six sets were tested 
representing (1) cell–cell adhesion (2) cytoskeleton (cell stiffness) (3) blood flow (4) disease 
biomarkers for stroke (5) disease biomarkers for hypertension and (6) random genes in the significant 
genome regions with functions unrelated to categories (1)–(5). The gene names and symbols for all 
genes contained within gene sets (1)–(5), and the intersections among the gene sets are given in the 
Supplementary file: Table S4 Gene Set Lists. 
Table 1. Genome regions defined by the top 20 SNPs from the genome-wide association analysis 
(GWAS) for which gene lists were downloaded from Ensembl (www.ensembl.org). 
Chromosome Region (Base-Pair Position) 
1 59,260,537–66,145,680 
3 27,229,795–43,322,328 
6 6,986,453 
8 73,183,865–73,188,285 
13 34,675,399–36,166,213 
14 20,883,247–22,023,889 
15 11,539,208 and 88,857,517 
23 47,893,418 
25 15,695,787–19,569,429 
26 35,008,287 
29 25,863,916 
Results of the fast set-based association analysis (fastBAT) [28] gene set analysis are summarized 
in Tables 2–4. 
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Table 2. Gene set analysis results for SNPs within gene boundaries. 
Gene Set No 
Genes 
No SNPs Chi-Square 
(Observed) 
p-Value Top SNP 
p-Value 
Top SNP 
Cell–cell 
adhesion 
43 59 90.73 0.0625 0.00018 BIEC2-287067 
Cytoskeleton 50 48 85.89 0.0267 0.00044 BIEC2-26621 
Blood flow 26 61 114.95 0.0198 0.00025 BIEC2-1062654 
Stroke 33 44 37.00 0.6322 0.0207 BIEC2-761299 
Hypertension 29 54 97.96 0.0257 0.00044 BIEC2-26621 
Random 258 121 177.12 0.0675 1.76 × 10−6 BIEC2-234438 
Table 3. Gene set analysis results for SNPs within 5 kb of gene boundaries. 
Gene Set No Genes No SNPs 
Chi-Square 
(Observed) p-Value 
Top SNP 
p-Value Top SNP 
Cell–cell 
adhesion 
43 64 95.25 0.0747 0.00019 BIEC2-287067 
Cytoskeleton 50 53 99.22 0.0158 0.00044 BIEC2-26621 
Blood flow 26 55 117.20 0.0066 0.00025 BIEC2-1062654 
Stroke 33 47 38.42 0.6691 0.0207 BIEC2-761299 
Hypertension 29 58 101.55 0.0309 0.0004 BIEC2-26621 
Random 258 145 226.31 0.0378 1.76 × 10−6 BIEC2-234438 
Table 4. Gene set analysis results for SNPs within 20 kb of gene boundaries. 
Gene Set No Genes No SNPs 
Chi-Square 
(Observed) p-Value 
Top SNP 
p-Value Top SNP 
Cell–cell 
adhesion 
43 72 99.93 0.1053 0.00019 BIEC2-287067 
Cytoskeleton 50 72 112.95 0.0473 0.00044 BIEC2-26621 
Blood flow 26 63 132.51 0.0058 0.00025 BIEC2-1062654 
Stroke 33 55 41.70 0.7610 0.0207 BIEC2-761299 
Hypertension 29 68 114.64 0.0351 0.0004 BIEC2-26621 
Random 258 195 287.99 0.0506 1.76 × 10−6 BIEC2-234438 
When SNPs were restricted to either those positioned within gene boundaries or up to 20 kb 
from the gene boundaries the significant gene sets were those with functions related to cytoskeleton 
(cell stiffness), blood flow and biomarkers for hypertension. There was intersection of gene content 
among the gene sets, with 5 genes (ABAT, CYFIP2, EMP2, FN1, TEK) being common to cell–cell 
adhesion, cytoskeleton organisation and blood flow, 9 genes (AAMP, ABAT, CYFIP2, EMP2, FN1, 
KCNMA1, RAPIGDS1, SGCD, TEK) intersecting between cytoskeleton organisation and blood flow, 
14 genes (ABAT, ADGRE2, B4GALT1, CDH13, CYFIP2, DLG5, EMCN, EMP2, FN1, FOXF1, IL12B, 
PLAU, PPP3CA, TEK) between cell–cell adhesion and blood flow and 11 genes (ABAT, ARPC2, 
CHMP5, CYFIP2, EMP2, FN1, SOCS1, TEK, TNS1, VCL, WHRN) between cell–cell adhesion and 
cytoskeleton organisation. 
The five genes which have functions related to all three physical model parameters (cell–cell 
adhesion, cytoskeleton organisation or cell stiffness and blood flow) are potentially important 
candidate genes influencing EIPH risk. ABAT (4 aminobutyrate aminotransferase) is a mitochondrial 
gene involved in the regulation of blood pressure and response to hypoxia. CYFIP2 (cytoplasmic 
FMR1-interacting protein 2) forms part of the VEGFA–VEGFR2 pathway and is associated in humans 
with susceptibility to Kawasaki disease and coronary artery lesions [29], interacting with PDE2A so 
that high-risk allele combinations account for 67% of cases in this human population. EMP2 
(epithelial membrane protein 2) regulates blood vessel endothelial cell migration and angiogenesis 
by regulating VEGF protein expression through PTK2 activation [30] and plays a role in the induction 
of VEGFA via a HIF1A-dependent pathway [31]. FN1 (Fibronectin) is involved in cell adhesion, cell 
motility, wound healing and maintenance of cell shape. TEK (angiopoietin-1 receptor) regulates 
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angiogenesis and endothelial cell survival, and is associated with pulmonary hypertension [32] and 
cutanomucosal venous malformation in humans. ABAT, CYFIP2, FN1 and TEK are all expressed in 
vascular and lung tissue, EMP2, FN1 and TEK are expressed in tracheal tissue (UniGene cDNA 
sources). Four further genes intersect between cytoskeleton and blood flow: AAMP (angio-associated 
migratory cell protein) is associated with angiogenesis and has potential roles in endothelial tube 
formation and the migration of endothelial cells, KCNMA1 (potassium calcium-activated channel 
subfamily M α 1), RAP1GDS1 (Rap1 GTPase-GDP dissociation stimulator 1) and SGCD (sarcoglycan 
delta) are associated with total anomalous pulmonary venous return [33]. 
The analysis of epistatic (gene–gene) interactions among the five genes which have roles in all 
three biological parameters or functions showed significant (p < 0.05) interactions between six SNPs 
representing all five genes (Appendix D). SNPs in EMP2, ABAT and FN1 had significant epistatic 
interaction with SNPs in CYFIP2 and TEK, and there was also interaction between SNPs in CYFIP2 
and TEK. Figure 3 illustrates the epistatic relationships among SNPs in the five genes. Haplotype 
analysis of SNPs within these five genes showed the haplotypes mostly significantly associated with 
the EIPH phenotype were in ABAT on chromosome 13 and CYFIP2 on chromosome 14 (Table 5). 
These results suggest that the interactions between the genotypes at ABAT, EMP2, CYFIP2, FN1 and 
TEK play an important role in determining EIPH risk. 
 
Figure 3. Schematic diagram of the epistatic relationships among SNPs in the genes ABAT, CYFIP2, 
EMP2, FN1 and TEK. Genes are represented as boxes, with the arrows showing significant epistatic 
interactions between them. The highlighted (red) boxes are the genes at which haplotypes are 
significantly associated with the exercise-induced pulmonary haemorrhage (EIPH) phenotype (Table 
5). 
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Table 5. Haplotypes spanning the genes ABAT and CYFIP2 which were significantly associated with 
the EIPH phenotype. At the ABAT gene, the haplotype GGGG was associated with increased risk, 
and the AGGA haplotype with reduced risk. A haplotype at the CYFIP2 gene was associated with 
increased risk. 
Chromosome BP Position Gene Haplotype β p-Value 
13 35,047,741–35,171,447 ABAT GGGG 0.084 7.44 × 10−8 
13 35,047,741–35,171,447 ABAT AGGA −0.037 0.013 
14 21,768,636–22,023,889 CYFIP2 GAAAAAAGAGG 0.151 0.00025 
4. Discussion 
The initial GWAS analysis identified three genome-wide significant regions associated with 
haemosiderophage score on chromosomes 3, 13 and 23, with the size of the regions ranging between 
1–16 Mb. Altogether, the top 20 SNPs from the GWAS were localised in 11 genome regions. These 
regions contain 412 genes with human homologues, and functions could be assigned to 375 of the 
genes. A novel gene set analysis (GSA) was carried out to test the significance of the physics model 
key parameters, cell–cell adhesion, cytoskeleton organisation (cell stiffness) and blood flow, allowing 
the complex nature of the trait to be incorporated into the analysis through the grouping of genes by 
related functions. The most significant gene sets represented the functions of cytoskeleton 
organisation (cell stiffness) and blood flow, highlighting these as key processes in the pathology of 
EIPH. Biomarkers for hypertension were also found to be significant suggesting that genetic variation 
impacting blood pressure could also be important, perhaps as a consequence of the relationship 
between blood pressure and flow. 
Several genes were contained within more than one gene set, with a sub-set of five genes 
affecting all three biological functions known to represent the key parameters in the physical model 
(cell–cell adhesion, cytoskeleton organisation and blood flow). These genes (ABAT, CYFIP2, EMP2, 
FN1, and TEK) are linked through their roles in promoting angiogenesis, particularly in response to 
hypoxic stress. TEK is the receptor for angiopoietin-1; the angiopoietin-1/TEK signalling complex 
regulates both maintenances of vascular quiescence and promotion of angiogenesis, with distinct 
signalling complexes being produced in the presence or absence of endothelial cell–cell adhesions 
[34]. Angiopoietin-1/TEK signalling also promotes microvascular integrity through interaction with 
the hypoxia-inducible factor HIF-2α. CYFIP2 is a target gene for p53, a protein essential for cellular 
response to oxygen stress which is regulated by HIF-1 [35]. EMP2 is upregulated under hypoxic 
conditions, promoting vascular endothelial growth factor (VEGF) expression through a HIF-1α 
dependent pathway [31]. ABAT is involved in response to hypoxia, and negative regulation of blood 
pressure (GO Biological Processes). The FN1 gene codes for the type I fibrin-binding domain in 
fibronectin. Polymerized fibrin is important in the process of coagulation and wound healing; faulty 
assembly or premature lysis of fibrin would increase the risk of haemorrhage. 
The hypoxia-inducible factors (HIFs), especially HIF-1α and HIF-2α, are key mediators of the 
adaptive response to hypoxic stress and play essential roles in maintaining lung homeostasis. Both 
human and animal genetic studies have shown that variants in HIF correlate with pulmonary 
vascular pathology and chronic lung diseases [36], including pulmonary arterial hypertension [37]. 
It has been postulated that inhibiting HIF could be a therapeutic target for pulmonary arterial 
hypertension (PAH) in humans [38]. Given the apparent similarities in the genetic background 
between PAH and EIPH, the inhibition of HIF might also provide therapeutic benefits for EIPH. 
Exercise and hypoxic conditions both increase angiogenesis, however, HIF signalling and gene 
expression are different under the two conditions. Exercise induces much larger changes in HIF 
expression levels compared with hypoxia alone [39]. Regular endurance training reduces skeletal 
muscle HIF expression under normoxic conditions [40], suggesting that HIF is involved in regulating 
adaptive gene response to exercise. Consequently, genetic variants increasing EIPH risk may also 
have effects on the HIF signalling pathway and response to training. Risk variants may have been 
maintained within the Thoroughbred racehorse population because they enhance muscle 
development and cardiovascular performance, as long as bleeding does not occur detrimentally. 
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The mechano-sensing roles of these genes are also important in vascular remodelling, as 
vascular endothelial cells are sensitive to stress and strain generated by blood flowing through the 
capillaries and venules. The mechano-sensitive and hypoxia responses are inter-linked; the hypoxia 
response has been shown to have a role in the differential expression of mechanosensitive genes 
within osteocytes [41], and it therefore seems plausible to expect that this relationship would also 
hold for other cells, such as vascular endothelial cells, which must respond to mechanical stresses. It 
is already known, for example, that microvascular integrity (vessel leakiness) is mediated by the role 
of angiopoietin 1 through a mechano-transduction pathway [42]. The interaction between the 
response to hypoxia and mechanical forces acting on endothelial cells appears to play a pivotal role 
in vascular remodelling, and the relationship between these responses merits further investigation. 
The nature of gene–gene interactions and pleiotropy within both the hypoxia and mechano-
transduction pathways also need to be better understood before firm conclusions can be drawn on 
the suitability of therapeutic targets for preventing or reducing EIPH. 
The physical model linking the EIPH phenotype to cellular biology and genetics has enabled 
candidate genes to be identified based on an understanding of their functional significance within 
the model. Further dissection of the biological pathways identified will elucidate the physiological 
benefits of genetic variants, in terms of cardiovascular enhancement and response to training/racing 
and the associated pathological risk of EIPH. This will enable improved therapies to be developed, 
as well as providing information required to reduce genetic risk within the Thoroughbred 
population. 
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Appendix A 
Tracheal Wash Cytology Images 
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Figure A1. Cytology images depicting an equine tracheal wash sample scored as 3 for the presence of 
red blood cells (A) and haemosiderophages (B). 
Appendix B 
Appendix B.1. A Physics-Based Model of EIPH 
Physiological studies have shown that during intense exercise a mean pulmonary arterial 
pressure (mPAP) above 80 mmHg is required to elicit bleeding in the lungs (Figure A1A) [21]. Such 
an increase in mPAP is not fully compensated by any other pressure and as a result the mean 
transmural pulmonary arterial pressure (mTPAP) follows mPAP trends (Figure A1B) [43] and the 
pressure across the capillary wall (mTPAP) is expected to promote a large increase in the capillary 
wall stress estimated to be 4 2~ 8.3 10 N/m×  for an mTPAP ~ 95mmHg  and capillary radius 
~ 3.3μm  during exercise [2]. Using the surface tension 4 2~ 8.3 10 N/mh× ×  where ~ 10μmh  is 
the capillary wall thickness [44] one finds 1~ 8.3 10 N/m−× . The physics model leads to two 
important conclusions: the first is that bleeding occurs under the form of an abrupt transition, which 
means that standard physics theory relating to a critical phenomenon (or phase transitions) should 
apply. The second is that the most important variable is the intra-capillary pressure which is not 
compensated and is linked to blood flow. In other words, the mTPAP written as ei PP −  where the 
indexes ‘i’ and ‘e’ refer to intra- and extra- respectively, can be rewritten as, 0ei PP − . 
Modelling the pathophysiology of blood vessel rupture requires modification of the physical 
model to incorporate biology. We have decomposed the problem into smaller steps which, when 
resolved and integrated, provide a better understanding of the pathophysiology of EIPH. The first 
step corresponds to determining the physical conditions for a vessel to rupture provided that the 
vessel has a constant lumen radius. The second step is to add to this the risk of bleeding and in 
particular the continuation of bleeding when the horse is exercising. The third step is to consider the 
contractile ability of vessels (i.e., arterioles or venuoles) to modulate vascular blood flow and 
pressure, and the relationship with bleeding. Once integrated these steps show the sensitivity of EIPH 
to key physical parameters. 
Appendix B.1.1. Part 1—Physics of Blood Vessel Rupture with Constant Radius under an Imposed 
Hydrostatic Pressure 
Physics theory can be applied to any vessel provided that their radius is constant. The first point 
to thus resolve is, given the fragility of capillaries, what capillary hydrostatic pressure is needed to 
rupture them in such a way that the rupture is large enough to let blood cells flow out. To model this 
phenomenon, we make use of the theory developed in physics to understand how fracture occurs in 
materials. We assume that capillaries can be modelled as a small shallow cylinder with a wall 
thickness h  constant length 0L  and radius R . In this context, the entire volume of the capillary is 
RLV 0π=  with a surface area of RLS 02π= . The mechanical tension or surface tension with unit 
2/J m  that is applied to the capillary wall is noted as, 0hσ , where 0σ  is the stress that is present 
within the capillary wall, which is assumed to be independent of the wall thickness. Laplace’s law 
then gives the relationship between the radius of the capillary, the surface tension and the pressure 
difference between the lumen of the capillary and the alveoli: ( )0 ~ i eh R P Pσ − . This last relation 
states that as the pressure difference increases, the surface tension increases in a similar proportion 
and it is expected that the increase in surface tension will fracture the capillary. 
To model the possibility of a capillary fracture of surface area ‘ s ’ it is noted that any fracture 
releases an energy Esh /~ 20σ−  where, E/20σ , is the energy density and E  the elastic modulus 
of the capillary wall and, sh  is the volume generated by the fracture. The fracture can only appear 
if cell–cell de-adhesion occurs so that cells can move apart. Assuming that the density of cell–cell 
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adhesion molecules is constant along the contour of cells, then the energy is proportional to the 
contour length of the fracture (the fracture ‘lips’). Noting by the variable ‘ l ’ the contour length and 
by ‘ λh ’ the cell–cell binding energy per unit of contour (i.e., λ  is an energy per surface area of 
adhesion), a drop in the surface tension energy is always accompanied by an increase of energy due 
to the presence of free lips given by hlλ2~  where the factor ‘2′ is added as each time a fracture 
appears two lips are generated. Let us consider that the contour length is proportional to the fracture 
area under the form: 2~ als  where a  is a geometrical constant such that for a circular fracture, 
π4/1=a . The variation of surface energy can be written as, EhalhlES /2~
2
0
2 σλ − . The surface 
energy represented in Figure A1(A) demonstrates that not all fractures diverge irreversibly but that 
a critical fracture size, 20/~ σλ aElc , needs to be attained. This allows ( )20 2~ llEES −  to be 
rewritten with 20
2
0 /~ σλ ahEE  and clll /=  (Figure A2(A)). This means that the capillaries can 
heal physically (and biologically) provided that the pressure difference or surface tension is small 
enough. This has been demonstrated in cell culture [45]. 
Appendix B.1.2. Part 2—Physics of Blood Vessel Rupture with the Presence of a Leak under an 
Imposed Hydrostatic Pressure 
The theory applied from material physics suggests that fractures diverge once a threshold size, 
2
0/~ σλ aElc , has been attained. However, in the vascular system, it is the blood flow that builds 
up the pressure inside vessels and if a leak occurs then it is possible to demonstrate that a fracture or 
rupture can be maintained. This point is important as racehorses undergoing intense exercise for a 
given time will probably bleed during the time considered. As shown above, the surface tension 
linked to the pressure inside vessels is also affected by the blood leaking as it is expected to lower the 
transmural capillary pressure. To model this we consider the internal volume of a capillary. The 
pressure difference changes are related to the amount of blood flowing into the capillary section 
under consideration. The extra blood flow rate in the capillary is noted as ‘ Vδ ’ and ‘τ ’ is the 
characteristic time related to the length of time the flow rate is increased. Note that the characteristic 
time is supposed to be long enough to apply thermodynamics and Vδ  can be related to basic 
haemodynamics for steady-state flows, i.e., the Hagen–Poiseuille equation. The product τδV  is 
therefore the extra volume present in the capillary and it is natural to assume that τδV  should 
increase the value of the lumen pressure, iP . To link iP  and τδV  a simple model is used whereby 
the volume of the capillary under consideration is constant. If more blood is poured into the section, 
iP  is expected to increase as a function of the proportion of extra volume being poured in. That is to 
say that for an incompressible fluid, i.e., the blood, at the lowest order ( )VVPP ii /1~ 0 τδ +  is 
obtained where 0iP  is the lumen pressure under normal/resting conditions. This relation allows the 
pressure difference to be written as, ( ) VVPPPPP ieiei /~ 00 τδ +−− . However, a fraction of this 
extra volume can be leaked out from the capillary lumen. Considering a capillary fracture of surface 
area ‘ s ’, the volume leaked per unit of time is therefore vs×~  where ‘v ’ is the blood velocity 
leaking out. Using Darcy’s law, the velocity is a function of the pressure difference between the inside 
and outside of the vessel, blood viscosity ‘ μ ’ and capillary wall thickness ‘h ’, expressed under the 
form, ( ) hsPPv ei μα /~ − , where ‘α ’ is the proportionality constant. Using 2~ als , the balance 
of volumes, i.e., what flows in minus what leaks out, can be re-expressed as: 
( ) hlPPaV ei ματτδ /42 −− . As a result the pressure difference in the presence of blood leaking out 
from the vessel can be rewritten as, ( )( )hVlPPaVVPPPPP eiieiei ματτδ //~ 4200 −−+−−  , 
which once rearranged gives: ( ) ( )hVlPaVVPPPPP iieiei ματτδ /1//~ 40200 ++−−  . It follows by 
virtue of Laplace’s law that new surface tension, ( )~ i eh R P Pσ − , can be defined: 
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( ) ( )hVlPaVVPPPRh iiei ματτδσ /1//~ 40200 ++−  . Noting ( )ei PPRh −00 ~σ  and 
00
0 /1/ VVhRPi =στ  one obtains: ( ) ( )hVlPaVV i ματδσσ /1//1~ 40200 ++  . In the expression of 
the new surface tension the presence of ‘ 4l ’ in the denominator confirms that the surface tension of 
the capillary decreases as a function of the rupture length. Within the latter relation the characteristic 
time ‘ τ ’ remains present but as a steady-state flow is considered it can be related to usual 
hemodynamic parameters. A simple dimensional analysis allows one to find that surface tension can 
also be expressed as a function of the steady-state flow rate in resting conditions under the form 
3
000 /~ RLVh μσ  . As 000 /1/ VVhRPi =στ , by identity one obtains, ( )200 /~/ RLPi μτ . 
Reintegrating these relations into the system’s energy one finds: 
( )
2
2 0
0 4
0
22 4
0 0
2
0
1 // ~ 2
1
/ /
~ /
S
c
c
V VE E l l
l
a L R l Vh
l E a
δ
α
λ σ
 +
−  
+ Ω 
Ω =
 
 
(A1) 
Equation (A1) plotted in Figure A2(B) captures the physical elements that are deemed important for 
EIPH. The bleeding transition can now be considered. 
Appendix B.1.3. Part 3—Physical Conditions for the Bleeding Transition 
While Equation (A1) captures most of the physics of EIPH, under this form it cannot provide 
any meaningful relationship between the physical variables supposedly involved in EIPH. However, 
it is clear that capillaries with poor cell–cell adhesion will probably have a tendency to bleed more, a 
result that comes automatically from Equation (A1). As a result, another relation needs to be 
introduced that links the physical variables together to determine the ‘bleeding transition’. 
The ‘no-bleeding’ condition up to the fracture can be captured by setting 0~0Ω  (this is the 
equivalent of saying that ~ 0α  in the absence of leaks), which transforms Equation (A1) into 
( )2020 /12~/ VVllEES δ+− . It is clear that the latter relation has an extreme value that is 
modulated by the blood flow and that is given when ‘ 1l ’ the solution of: ( ) 0~// 0 lEES ∂∂  leading 
to ( )21 0~ 1/ 1 /l V Vδ+    with a resulting extreme value for the energy: 
( ) ( )200max /12/~ VVEES δ+ . The blood flow, therefore, modulates the energy barrier leading to 
rupture. Furthermore the thermal energy TkB  (where Bk  is Boltzmann’s constant and T  the 
absolute temperature) modulates the energy of this fundamental state to generate statistical thermal 
fluctuations and it is when this fluctuation is enough to promote a fracture that the bleeding transition 
occurs. Putting ( ) TkE BS ~max , i.e., that the thermal energy needs to match the extrema value of the 
potential, one finds a simple critical relation: 
( )2 2 20 02 1 / ~ /c BV V k T hE aδ λ σ+    , (A2) 
where 0 0/ / 1c cV V V Vδ = −     and cV  correspond to a critical flow rate that using Equation (A2) can 
be rewritten simply as: 2 20 0~ / 2c BV V hE a k Tλ σ  . Using 20~ /cl E aλ σ  (Equation (A1)) one 
obtains a simple expression of cV  under the form: 0~ / 2c c BV V hl k Tλ  . 
As the model is expected to provide prior-information to genetic analysis it is essential to 
demonstrate its coherence with existing data. The relation, 2 20 0~ / 2c BV V hE a k Tλ σ  , derived 
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from Equation (A2) links the macroscopic parameter, 0/cV V  , to microscopic ones, 
2 2
0/ 2 BhE a k Tλ σ , that have all been separately determined experimentally. Given that capillary 
rupture occurs at the level of cell–cell adhesion, as the interaction energy involving cell–cell adhesion 
complexes is typically ~ 100 Bk T  [46] and that the surface density for adhesive units involved 
between adjacent cells 3 -2~ 10 μm [47], one deduces a typical value of 5 2B~ 10 k T/μmλ . Using 
JTkB
21103~ −×  (at KT 300~  i.e., a temperature of o27 C ) leads to 4 2~ 3 10 /J mλ −⋅ . 
Considering capillary stress 4 20 ~ 8 10 /N mσ × [3], an elastic modulus per cell PaE 310~  [48], 
and a typical capillary wall thickness 6~ 10h m−  and π4/1=a  one finds 
2 2
0/ 2 ~ 5 6BhE a k Tλ σ − . To determine 0/cV V   it can be legitimately assumed that 0/cV Vδ    is 
linearly linked to the transmural pressure variation inside the vessel (This assumption can be justified 
as follow: Using ( ) VVPPPPP ieiei /~ 00 τδ +−− , the blood flow can be related to a critical pressure 
difference, i.e., a critical transmural pressure, under the form: ( )0 0 0~ / ~ / 1c i i cP P V V P V Vδ δ τ × −  
.) namely, 0 0/ ~ /c cP P V Vδ δ   . Then the use of Figure A1(A) allows one to predict that 0/ ~ 4cV V   
(or 0/ ~ 3cV Vδ   ). The order of magnitudes is similar, suggesting that the model is sound to be used 
further. 
Based on the similarity above, one can also provide an order of magnitude for cl  that can be 
rewritten as, 20/ ~ /cl h E ahλ σ× . As described above, the term 20 / Eσ  is the energy density of 
the capillary wall meaning that, 20 /h Eσ , has an order of magnitude similar to the surface tension 
of the wall. Using 20 / ~ 0.8 /h E N mσ  and 1/ 4a π=  one finds ~ 30cl nm . It is worth noting 
that with the value of cl  now defined, it is expected that 0 1Ω <<  as 40 ~ clΩ . While Equation 
(A2) provides the physical conditions required to be fulfilled for bleeding it does not provide any 
information on the amount of blood crossing the vessel wall. 
Appendix B.1.4. Part 4—Physical Pathophysiology of EIPH 
The main question is to find the relation that allows sustained bleeding to occur. Considering 
0 1Ω << , Equation (A1) can be rewritten as a Taylor’s expansion (chain rule method) up to the 6th 
power of the energy around 0~l  under the form: 
( ) ( ) 62002200 /12/12~/ lVVlVVlEES  δδ +Ω++− . (A3) 
The term in ‘ 6l ’ provides for maintenance of the leak. As shown in Figure A2(B), Equation (A3) 
demonstrates the presence of two extrema. The order of magnitude of the maximum, noted 1l , 
results from the competition between the two first terms that are present in the right-hand-side of 
Equation (A3) leading to ( )21 0~ 1/ 1 /l V Vδ+   , which is one solution determined previously. 
Likewise the minimum, noted 2l , results from the competition between the two last terms that are 
present in the right-hand-side of Equation (A3), leading to 42 0~ 1 /l Ω . It is worth noting here that 
using Equation (A1) to replace 0Ω  by its literal expression one finds, ( )1/422 0~ /l R h a Lπ α , that 
is to say that the size of the capillary rupture is chiefly imposed by the radius of the capillaries. Finally, 
the maintenance of the leak appears only if 2 1l l≥  that is: 
( )( ) ( )1/4 22 0 0/ / 1/ 1 /cR l h a L V Vπ α δ≥ +   . In the latter relation there are only two meaningful 
physical and physiological parameters, namely cl  and 0/V Vδ    that, as a result, suggests that the 
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leak can be maintained only if the ratio ( )20/ 1 /cl V Vδ+    is smaller than a given constant, i.e., 
( )1/42 0/R h a Lπ α , which is linked to the geometry of the capillaries. In view of this last result the 
prior information that physics gives in terms of genetic sensitivity to EIPH can be discussed. To start 
with the critical length, 20~ /cl E aλ σ , is a ratio between the energy involved in cell–cell adhesion 
and the stiffness of cells suggesting that if the adhesion diminishes, for example by a reduction in the 
number of cadherins, and/or that the stiffness of cells increases, for example by augmenting the 
stiffness of the cytoskeleton, EIPH is more likely to occur. However the presence of the squared term 
in ratio, ( )20/ 1 /cl V Vδ+   , means that EIPH is potentially more sensitive to the blood flowing into 
capillaries which may result from physiological or anatomical changes in the vascular system, for 
example when venules have a smaller diameter [6–8] or following the selection of racehorses with 
larger cardiac outputs [49]. In any case, contrary to what has previously been suggested [50], blood 
viscosity does not seem to be involved. 
 
Figure A1. (A) Impact of the mean pulmonary arterial pressure (mPAP) on bleeding, data from [21]. 
(B) mPAP is not fully compensated by any other pressure and as a result, the mean transmural 
pulmonary arterial pressure (mTPAP) follows mPAP trends, data from [43]. 
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Figure A2. (A) Fracture definition in material physics: The initial state (thick red arrow) can be 
modulated by the thermal energy and when the tension is enough a fracture opens up in which case 
the red circle, which schematically represents the state of the fracture, ‘jumps’ above the energy 
barrier to generate fractures which are the largest possible. In this model there is no compensatory 
mechanism (i.e., a reduction of the tension due to fracture) hence the description ‘the largest possible’ 
remains valid. (B) When a compensatory mechanism is involved, namely when there is reduction of 
the tension due to the fracture, new stable states (e.g., thick red arrows on the right) emerge from the 
system leading to sustained fracture. However, the ability of the fracture to be sustained is a function 
of the value of omega which presents an inflection when its value is above 1/60 (green curve). In this 
case fractures do not appear however much the fracture can ‘jump’. It is the value of omega and thus 
the type of vessel that will determine whether the fracture is maintained (leading to a bleeding state) 
or not. The maximum and minimum value of the energy are located at 1l  and 2l , respectively. (C) 
An interesting phenomenon is the bleeding oscillation that should occur when the tension energy is 
sufficiently large for the system’s energy to match the thermal energy. In this context constant opening 
and closing configurations are possible. (D) In the case of increased bloodflow, the system’s energy 
landscape changes leading to the appearance of new stable modes (i.e., fracture lengths) that were not 
present before. 
Appendix C 
Genome-Wide Association Top 20 SNPs 
Table A1. Top 20 SNPs from the GWAS with unadjusted (Unadj), Bonferroni single step adjusted 
(Bonf), Benjamini and Hochberg (1995) step-up false discovery rate control (FDR_BH) and Benjamini 
and Yekutieli (2001) step-up false discovery rate control (FDR_BY) p-values. 
Chromosome SNP Name Unadj Bonf FDR_BH FDR_BY 
3 BIEC2-774953 1.25 × 10−7 0.0055 0.0055 0.0613 
23 BIEC2-626135 4.48 × 10−7 0.0195 0.0097 0.1095 
13 BIEC2-233640 1.06 × 10−6 0.0450 0.0153 0.1718 
13 BIEC2-233687 1.76 × 10−6 0.0763 0.0153 0.1718 
13 BIEC2-234438 1.76 × 10−6 0.0763 0.0153 0.1718 
13 BIEC2-233294 2.11 × 10−6 0.0919 0.0153 0.1724 
1 BIEC2-27502 1.83 × 10−5 0.7942 0.1135 1 
13 BIEC2-233191 4.50 × 10−5 1 0.2445 1 
25 BIEC2-662769 9.31 × 10−5 1 0.4497 1 
14 BIEC2-248255 0.000117 1 0.4641 1 
14 BIEC2-248094 0.000117 1 0.4641 1 
6 BIEC2-938252 0.000162 1 0.5746 1 
15 BIEC2-325838 0.000182 1 0.5746 1 
15 BIEC2-287067 0.000185 1 0.5746 1 
26 BIEC2-693883 0.000253 1 0.5763 1 
8 BIEC2-1062654 0.000253 1 0.5763 1 
8 BIEC2-1062668 0.000253 1 0.5763 1 
25 BIEC2-661835 0.000257 1 0.5763 1 
29 BIEC2-760805 0.000268 1 0.5763 1 
1 BIEC2-24798 0.000364 1 0.5763 1 
Appendix D 
Epistatic Interactions between SNPs in Five Key Genes from the Gene Set Analysis with Biological Functions 
Relating to Cell–cell Adhesion, Cytoskeleton Organisation (Cell Stiffness) and Blood Flow 
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Table A2. Significant epistatic interactions (p < 0.05) between SNPs on chromosomes 6, 13, 14 and 23 
located within or flanking the genes ABAT, EMP2, CYFIP2, FN1 and TEK. 
Chr 1 SNP 1 Chr 2 SNP 2 β Interaction p-Value 
6 BIEC2-937111 14 BIEC2-248213 0.068 0.046 
6 BIEC2-937111 23 BIEC2-625265 0.062 0.026 
13 BIEC2-232441 14 BIEC2-248202 -0.042 0.036 
13 BIEC2-232441 14 BIEC2-248209 -0.043 0.018 
13 BIEC2-232441 14 BIEC2-248210 -0.056 0.001 
13 BIEC2-232441 14 BIEC2-248213 0.060 0.001 
13 BIEC2-232441 14 BIEC2-248227 0.069 0.000 
13 BIEC2-232441 14 BIEC2-248229 0.070 0.000 
13 BIEC2-232441 14 BIEC2-248255 0.202 0.012 
13 BIEC2-232441 23 BIEC2-625253 -0.060 0.010 
13 BIEC2-232525 14 BIEC2-248202 -0.067 0.021 
13 BIEC2-232525 14 BIEC2-248213 0.058 0.027 
13 BIEC2-232525 14 BIEC2-248227 0.065 0.016 
13 BIEC2-232525 14 BIEC2-248229 0.055 0.038 
13 BIEC2-233585 13 BIEC2-233626 -0.063 0.007 
13 BIEC2-233585 14 BIEC2-248202 -0.050 0.012 
13 BIEC2-233585 14 BIEC2-248227 0.035 0.044 
13 BIEC2-233585 14 BIEC2-248229 0.035 0.043 
14 BIEC2-248202 14 BIEC2-248210 0.038 0.013 
14 BIEC2-248202 14 BIEC2-248213 -0.036 0.030 
14 BIEC2-248202 14 BIEC2-248227 -0.047 0.018 
14 BIEC2-248202 14 BIEC2-248229 -0.040 0.019 
14 BIEC2-248209 14 BIEC2-248227 -0.042 0.049 
14 BIEC2-248210 14 BIEC2-248213 -0.039 0.039 
14 BIEC2-248210 14 BIEC2-248227 -0.045 0.014 
14 BIEC2-248210 14 BIEC2-248229 -0.043 0.019 
14 BIEC2-248213 14 BIEC2-248227 0.043 0.012 
14 BIEC2-248213 14 BIEC2-248229 0.041 0.017 
14 BIEC2-248227 14 BIEC2-248229 0.041 0.017 
14 BIEC2-248255 23 BIEC2-625247 -0.106 0.026 
14 BIEC2-248255 23 BIEC2-625253 -0.201 0.012 
14 BIEC2-248255 23 BIEC2-625265 -0.098 0.039 
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